According to the research report, the Asia Pacific Multiplex Assays Market size has been valued at USD 0.69 billion in 2021. It is expected to worth USD 1.04 billion by 2026, hiking at 8.41% CAGR.
A multiplex assay is a type of assay used in research to simultaneously measure multiple analytes simultaneously in a single run. It is different from the procedures that measure only one analyte at a time. They are extensively used in experiments involving functional genomics. These experiments are attempted to detect or to assay the state of all biomolecules of a given class (e.g., mRNAs, proteins) in a biological sample, to determine the effect of an experimental treatment or the effect of a DNA mutation over all of the biomolecules or pathways in the sample. The skill to perform multiplex assay experiments measuring large numbers of biomolecular analytes can be credited with completing the human genome sequence and that of many other model organisms.
This can be credited to the increasing geriatric population, rising prevalence of cataracts, and increasing government initiatives to eliminate avoidable blindness. Moreover, the increase in the adoption of the premium lens due to their enhanced visual performance ensures reduced astigmatism rates, thus boosting the growth of the market.
However, unfavorable reimbursement schemes and postoperative complications such as refractive errors are expected to have a negative impact on market growth.
This research report on the Asia Pacific Multiplex Assays Market has been segmented and sub-segmented into the following categories:
By Product:
By Type:
By Technology:
By Application:
By End User:
By Country:
Regionally, Asia-pacific is expected to witness the highest growth rate in the coming years owing to developing countries like India and China. Factors such as increasing the number of the patient population, increased prevalence of Alzheimer patients, and a significant rise in research & development activities in pharmaceuticals for the treatment of diseases, such as cancer and Alzheimer’s.
Companies that are currently dominating the APAC Multiplex Assays Market profiled in the report are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Abcam Plc, Becton, Dickinson and Company, Luminex Corporation, Meso Scale Diagnostics, Randox Laboratories Ltd and Seegene Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.3 Instruments
5.1.4 Accessories
5.1.5 Software and Services
5.1.6 Y-o-Y Growth Analysis, By Product
5.1.7 Market Attractiveness Analysis, By Product
5.1.8 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Nucleic Acid-Based Multiplex Assays
5.2.2.1 Planar Nucleic Acid Assays
5.2.2.2 Bead-Based Nucleic Acid Assays
5.2.3 Protein-Based Multiplex Assays
5.2.3.1 Planar Protein Assays
5.2.3.2 Bead-Based Protein Assays
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Research & Development
5.3.2.1 Drug Development
5.3.2.2 Biomarker Discovery and Validation
5.3.3.1 Infectious Diseases
5.3.3.2 Cancer
5.3.3.3 Cardiac Diseases
5.3.3.4 Autoimmune Diseases
5.3.3.5 Alzheimer’s Disease
5.3.3.6 Allergies
5.3.3 Companion Diagnostics
5.3.4 Other Applications
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 Technology
5.4.1 Introduction
5.4.2 Multiplex Pcr
5.4.3 Multiplex Arrays
5.4.3.1 Multiplex Planar Arrays
5.4.3.2 Multiplex Bead-Based Array
5.4.4 Other Technologies
5.4.5 Y-o-Y Growth Analysis, By Technologies
5.4.6 Market Attractiveness Analysis, By Technologies
5.4.7 Market Share Analysis, By Technologies
5.5 End Use
5.5.1 Introduction
5.5.2 Pharmaceutical & Biotechnology Companies
5.5.3 Academic & Research Institutes
5.5.4 Clinical Laboratories
5.5.5 Hospitals
5.5.6 Other End Users
5.4.5 Y-o-Y Growth Analysis, By End Use
5.4.6 Market Attractiveness Analysis, By End Use
5.4.7 Market Share Analysis, By End Use
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Application
6.1.3.5 By Technology
6.1.3.6 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Application
6.1.4.5 By Technology
6.1.4.6 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Application
6.1.5.5 By Technology
6.1.5.6 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Luminex Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific Inc.
8.3 Illumina Inc.
8.4 Bio-Rad Laboratories Inc.
8.5 QIAGEN N.V.
8.6 Abcam Plc
8.7 Becton
8.8 Dickinson and Company
8.9 Luminex Corporation
8.10 Meso Scale Diagnostics
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
